Arecor Awarded Biomedical Catalyst Funding Towards £1.3 Million Project
Cambridge, England (ots/PRNewswire) - Cambridge biotech company Arecor has been awarded GBP785,000 from the government-backed Biomedical Catalyst Fund to accelerate the development of high concentration antibodies to allow more convenient administration of our future therapeutic medicines and reduce healthcare costs. Arecor has recently demonstrated Proof of Concept in ...
mehr